Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Fibromyalgia Syndrome
Interventions
DRUG

Roujin Formula

48 eligible participants with FMS of blood deficiency and liver depression syndrome were selected and randomly divided into treatment group(n=24)and control group(n=24). The treatment group was given Roujin Foumula 150mL,twice a day; The control group was given Roujin Foumula placebo 150mL,twice a day,the study period was 8 weeks. The evaluation points were 0 weeks,4 weeks,and 8 weeks of treatment,and follow-up to 12 weeks. To evaluate the effect changes before and after treatment,FIQR score、VAS score、PSQI score、BDI score and SF-36 PCS、MCS score were used as secondary efficacy evaluation indexes. SPSS23.0 was used to analyze the data.

Trial Locations (1)

100053

Juan Jiao, Beijing

All Listed Sponsors
lead

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER

NCT06285045 - Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression | Biotech Hunter | Biotech Hunter